Carfilzomib
High Risk
The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 81/ 100
Competitive context
10 Active assets in the High Risk cohort.
View all 17 →
Same molecule, other indications
Carfilzomib is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →